The pharmaceutical world is seeing a remarkable shift in diabetes management with the introduction of GLP-1 transdermal devices. These systems offer a possibly more user-friendly alternative to injections of GLP-1 receptor agonists, lessening the frequency of daily needle sticks. The innovation releases the compound directly through the skin, po… Read More